ストックスクリーナーアプリを入手
1.14
1.72%
-0.02
アフターアワーズ：
1.14
Bionano Genomics Inc (BNGO) 最新ニュース
Price to sales forward of Bionano Genomics, Inc. – NASDAQ:BNGO - TradingView
BNGO Should I Buy - Intellectia AI
Bionano Genomics, Inc. (BNGO) reports Q1 loss, tops revenue estimates - MSN
Bionano Genomics, Inc. Actuals & Estimates (NASDAQ:BNGO) - TradingView
BNGO Forecast — Price Target — Prediction for 2027 - TradingView
Bionano Genomics, Inc. Announces Appointment of Alex Hastie to Chief Scientific Officer, Effective July 20, 2026 - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
Bionano Genomics Names Alex Hastie Chief Scientific Officer - The Globe and Mail
Bionano Genomics appoints Alex Hastie as chief scientific officer - Investing.com UK
Bionano Genomics appoints Alex Hastie as chief scientific officer By Investing.com - Investing.com South Africa
Bionano Genomics Appoints Dr. Alex Hastie as Chief Scientific Officer to Drive Innovation in Optical Genome Mapping - Minichart
Bionano Genomics Appoints Alex Hastie as Chief Scientific Officer - Quiver Quantitative
Bionano appoints Alex Hastie as Chief Scientific Officer to lead global science strategy - TradingView
Bionano Announces Hiring of Chief Scientific Officer - marketscreener.com
Alex Hastie returns as Chief Scientific Officer at Bionano Genomics (NASDAQ: BNGO) - Stock Titan
Bionano brings back OGM pioneer to lead science strategy July 20 - Stock Titan
Bionano Genomics Inc (BNGO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BNGO Q1 2026 Earnings: EPS Surprises to the Upside Amid Continued Operational ChallengesEPS Revision Trend - dars.gov.et
Bionano Genomics (BNGO) Sees Significant Growth in Optical Genome Mapping Studies - GuruFocus
Bionano Genomics reports 67% increase in studies at genetics conference - Investing.com
Bionano Genomics reports 67% increase in studies at genetics conference By Investing.com - Investing.com Canada
Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption - The Manila Times
Bionano’s genome-mapping studies jump to 35 at ESHG 2026 - Stock Titan
Bionano Genomics Inc (BNGO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bionano Genomics Inc (BNGO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bionano Genomics Inc (BNGO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bionano Genomics Inc (BNGO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bionano Genomics Inc (BNGO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bionano Genomics Inc (BNGO) Institutional Confidence - TradingKey
Bionano Genomics Inc (BNGO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bionano Genomics Inc (BNGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bionano Genomics Keeps Penny Stock Risk In Focus - Kalkine Media
Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders - The Manila Times
Infertility gene clues: 13 studies find hidden variants with Bionano mapping - Stock Titan
BNGO News | BIONANO GENOMICS INC (NASDAQ:BNGO) - ChartMill
Bionano Genomics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo
Bionano Genomics (BNGO) upgraded to buy: What does it mean for the stock? - MSN
Bionano Genomics (BNGO) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
BioNano Genomics Announces Resignation of Chief Medical Officer - The Globe and Mail
Bionano Genomics (NASDAQ: BNGO) Chief Medical Officer to step down - Stock Titan
Bionano Genomics, Inc. Announces Resignation of Alka Chaubey as Chief Medical Officer, Effective July 5, 2026 - marketscreener.com
Bionano appoints board chairman as interim CEO - Investing.com
BNGO Q1 2026 Earnings: Surprise EPS Beat Amid Revenue Disclosure AbsenceAnalyst Coverage Count - dars.gov.et
Bionano Genomics (BNGO) CMO has 24 vested shares withheld for tax obligations - Stock Titan
Bionano Genomics (BNGO) counsel has 24 shares withheld for RSU taxes - Stock Titan
Bionano Genomics (BNGO) officer reports 7-share tax withholding - Stock Titan
Bionano (BNGO) Q1 2026 Earnings Transcript - The Globe and Mail
Bionano Genomics names board chair Luderer interim CEO - MSN
Bionano Genomics (BNGO) Edges Higher Amidst Tight Trading RangeMoving Average Crossovers - dars.gov.et
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO) and BioLife Solutions (BLFS) - The Globe and Mail
Maxim Group Maintains Bionano Genomics(BNGO.US) With Buy Rating, Maintains Target Price $4 - Moomoo
BioNano Genomics Retires Secured Debt, Boosts Flexibility - The Globe and Mail
Bionano Genomics Fully Retires $20 Million Secured Debt, Boosting Financial Flexibility for Future Growth 1 - Minichart
1.24%
2.13%
大文字化:
|
ボリューム (24 時間):